Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1963 2
1965 4
1966 9
1967 24
1968 20
1969 24
1970 10
1971 19
1972 18
1973 20
1974 13
1975 11
1976 18
1977 17
1978 9
1979 6
1980 10
1981 7
1982 9
1983 9
1984 12
1985 7
1986 12
1987 14
1988 14
1989 10
1990 17
1991 14
1992 11
1993 15
1994 12
1995 21
1996 25
1997 30
1998 19
1999 26
2000 27
2001 23
2002 29
2003 34
2004 36
2005 22
2006 40
2007 37
2008 42
2009 48
2010 57
2011 57
2012 65
2013 81
2014 94
2015 99
2016 92
2017 86
2018 74
2019 73
2020 62
2021 49
2022 30
2023 31
2024 38
2025 40
2026 22

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,737 results

Results by year

Filters applied: . Clear all
Page 1
Cardiac Effects of Sulfonylurea-Related Hypoglycemia.
Middleton TL, Wong J, Molyneaux L, Brooks BA, Yue DK, Twigg SM, Wu T. Middleton TL, et al. Diabetes Care. 2017 May;40(5):663-670. doi: 10.2337/dc16-1972. Epub 2017 Feb 21. Diabetes Care. 2017. PMID: 28223296
OBJECTIVE: To determine the effect of sulfonylurea-related hypoglycemia on cardiac repolarization and ectopy in the setting of well-controlled type 2 diabetes. ...CONCLUSIONS: Hypoglycemia, often unrecognized, is a frequent finding in well-controlled sulfo …
OBJECTIVE: To determine the effect of sulfonylurea-related hypoglycemia on cardiac repolarization and ectopy in the setting of …
Diabetes Deprescribing in Older Adults: A Randomized Clinical Trial.
Grant RW, Peterson I, McCloskey JM, Lipska KJ, Nugent J, Karter AJ, Gilliam LK. Grant RW, et al. JAMA Intern Med. 2025 Aug 1;185(8):926-935. doi: 10.1001/jamainternmed.2025.2015. JAMA Intern Med. 2025. PMID: 40549370 Clinical Trial.
IMPORTANCE: Medication-related hypoglycemia is the leading cause of iatrogenic complications among older adults with type 2 diabetes. ...There was not a statistically significant difference in severe self-reported hypoglycemia at 6 months between the AD plus previsi …
IMPORTANCE: Medication-related hypoglycemia is the leading cause of iatrogenic complications among older adults with type 2 diabetes. …
Pharmacogenetics of hypoglycemia associated with sulfonylurea therapy in usual clinical care.
Mitchell SL, Leon DAC, Chaugai S, Kawai VK, Levinson RT, Wei WQ, Stein CM. Mitchell SL, et al. Pharmacogenomics J. 2020 Dec;20(6):831-839. doi: 10.1038/s41397-020-0171-4. Epub 2020 Jun 5. Pharmacogenomics J. 2020. PMID: 32504053 Free PMC article.
Hypoglycemia is a common complication among type 2 diabetes mellitus (T2DM) patients receiving sulfonylurea therapy. ...In a retrospective case-control study in European American patients with T2DM, we examined the potential association between CYP2C9 reduced-functi …
Hypoglycemia is a common complication among type 2 diabetes mellitus (T2DM) patients receiving sulfonylurea therapy. ...In a r …
Pharmacogenetics of sulfonylurea-induced hypoglycemia in Type 2 diabetes patients: the SUCLINGEN study.
Loganadan NK, Huri HZ, Vethakkan SR, Hussein Z. Loganadan NK, et al. Pharmacogenomics. 2021 Nov;22(16):1057-1068. doi: 10.2217/pgs-2021-0059. Epub 2021 Oct 19. Pharmacogenomics. 2021. PMID: 34665019
Hypoglycemia was defined as having symptoms or a blood glucose level <3.9 mmol/l. Results: Of the 401 patients, 120 (29.9%) developed sulfonylurea-induced hypoglycemia during the 12-month follow-up. ...Conclusion: Sulfonylurea-treated T2D patients w …
Hypoglycemia was defined as having symptoms or a blood glucose level <3.9 mmol/l. Results: Of the 401 patients, 120 (29.9%) develo …
[Successful treatment of severe sulfonylurea-induced hypoglycemia by the subcutaneous administration of octreotide in an elderly patient with diabetes: A case report].
Nakaya M, Oka R, Miyamoto S. Nakaya M, et al. Nihon Ronen Igakkai Zasshi. 2019;56(3):336-342. doi: 10.3143/geriatrics.56.336. Nihon Ronen Igakkai Zasshi. 2019. PMID: 31366755 Free article. Japanese.
Sulfonylureas, a potent stimulator of insulin release from pancreatic beta cells, can cause hypoglycemia, which is apt to recur with a prolonged duration in elderly patients. ...In conclusion, the subcutaneous injection of octreotide can be an effective and s …
Sulfonylureas, a potent stimulator of insulin release from pancreatic beta cells, can cause hypoglycemia, which is apt to recu …
Octreotide: an antidote for sulfonylurea-induced hypoglycemia.
McLaughlin SA, Crandall CS, McKinney PE. McLaughlin SA, et al. Ann Emerg Med. 2000 Aug;36(2):133-138. doi: 10.1067/mem.2000.108183. Ann Emerg Med. 2000. PMID: 10918104
In overdose, these agents can produce sustained and profound hypoglycemia that is refractory to treatment with dextrose alone. Our objective was to determine whether treatment with octreotide decreases glucose requirements and the number of hypoglycemic episodes in patient …
In overdose, these agents can produce sustained and profound hypoglycemia that is refractory to treatment with dextrose alone. Our ob …
Fasting hypoglycemia.
Baruh S, Sherman L, Kolodny HD, Singh AJ. Baruh S, et al. Med Clin North Am. 1973 Nov;57(6):1441-62. doi: 10.1016/s0025-7125(16)32200-3. Med Clin North Am. 1973. PMID: 4355740 Review. No abstract available.
Severe hypoglycemia in users of sulfonylurea antidiabetic agents and antihyperlipidemics.
Leonard CE, Bilker WB, Brensinger CM, Han X, Flory JH, Flockhart DA, Gagne JJ, Cardillo S, Hennessy S. Leonard CE, et al. Clin Pharmacol Ther. 2016 May;99(5):538-47. doi: 10.1002/cpt.297. Epub 2016 Jan 17. Clin Pharmacol Ther. 2016. PMID: 26566262 Free PMC article.
Drug-drug interactions causing severe hypoglycemia due to antidiabetic drugs is a major clinical and public health problem. We assessed whether sulfonylurea use with a statin or fibrate was associated with severe hypoglycemia. ...Concomitant therapy with a …
Drug-drug interactions causing severe hypoglycemia due to antidiabetic drugs is a major clinical and public health problem. We assess …
[Sulfonylurea-induced factitious hypoglycemia].
Svirski B, Edoute Y. Svirski B, et al. Harefuah. 1996 May 15;130(10):678-80, 727. Harefuah. 1996. PMID: 8794657 Hebrew.
By demonstrating sulfonylurea in their urine, a definitive diagnosis of factitious hypoglycemia was established, and further invasive procedures were avoided. The third was a woman aged 40-years had malignant insulinoma with liver metastases, proven by cytolo …
By demonstrating sulfonylurea in their urine, a definitive diagnosis of factitious hypoglycemia was established, and further i …
1,737 results